Data Foundry

Drug recalls 2025

NIACIN Extended-Release Tablets — Class II drug recall D-0158-2026

Ongoing recall by Golden State Medical Supply Inc., reported 2025-11-26, distributed nationwide. Failed Dissolution Specifications

Recall numberD-0158-2026
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmGolden State Medical Supply Inc., Camarillo, CA, United States
Recall initiated2025-10-20
Classified2025-11-19
Reported by FDA2025-11-26
DistributedNationwide (US)
Quantity24,869 bottles
Reason classesspecification failure
NDC51407-0267, 51407-0267-90, 51407-0268, 51407-0268-90
Lot numbersGS044385, GS044979, GS045797, GS046415, GS047197, GS047786, GS048477, GS048873, GS049480, GS049733, GS050224, GS050721, GS050722, GS051145, GS051726, GS052484, GS053612, GS054409, GS054987, GS055697, GS056192, GS056886, GS057330, GS058077
Expiration dates2025-10, 2025-12, 2026-02, 2026-03, 2026-04, 2026-05

Product

NIACIN Extended-Release Tablets, USP, 1,000 mg, 90 tablets per bottle, Rx only, Manufactured by: Kremers Urban Pharmaceuticals, Inc., a subsidiary of Lannett Company, Inc., Seymour, IN 47274. Packaged by GSMS, Incorporated, Carmarillo, CA 93012. NDC: 51407-268-90

Reason for recall

Failed Dissolution Specifications

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0158-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.